INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?

INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?

ABSTRACT BACKGROUND: The interaction between serum lipids and C virus infection is well known, as are serum lipid levels in the Peg-IFN / RBV-based treatment. However, with direct action antivirals (DAAs) this behavior is still unclear. OBJECTIVE: To compare serum lipids levels between patients...

Full description

Bibliographic Details
Main Authors: Vanessa Gutierrez de ANDRADE, Fabio da Silva YAMASHIRO, Cassio Vieira OLIVEIRA, Leticia Lastória KUROZAWA, Alecsandro MOREIRA, Giovanni Faria SILVA
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
Series:Arquivos de Gastroenterologia
Subjects:
Hepatite C
Metabolismo dos lipídeos
Análise virológica
Interferon-alfa
Antivirais, uso terapêutico
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032018000200184&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032018000200184&lng=en&tlng=en

Similar Items